Search research articles
Contact Us
Filters
Showing results (151-160 of 193) with videos related to
Page
of 20
Sort By:
Haematology and Blood Transfusion
|
January 1, 1987
Long-term results of two Swiss AML studies
C Sauter, P Alberto, W Berchtold, et al.
Journal of the Endocrine Society
|
December 22, 2017
Temperature as a Circadian Marker in Older Human Subjects: Relationship to Metabolic Syndrome and Diabetes
Brianna D Harfmann, Elizabeth A Schroder, Jonathan H England, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2015
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
A S Coates, E P Winer, A Goldhirsch, et al.
British Journal of Cancer
|
November 1, 1996
Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy. Swiss Group for Clinical Cancer Research (SAKK)
J Bernhard, C Hürny, M Bacchi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 1, 1993
The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG)
C Hürny, J Bernhard, M Bacchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study Group
C Hürny, J Bernhard, A Coates, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group
C Hürny, J Bernhard, R D Gelber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1995
Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK)
R A Joss, M Bacchi, C Hürny, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1986
Swiss adjuvant trial (OSAKO 06/74) with chlorambucil, methotrexate, and 5-fluorouracil plus BCG in node-negative breast cancer patients: nine-year results
H J Senn, W F Jungi, R Amgwerd, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1995
Interferon-alpha for induction and maintenance in multiple myeloma: results of two multicenter randomized trials and summary of other studies
H Ludwig, A M Cohen, A Polliack, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 193) with videos related to
Sort By:
Page
of 20
Haematology and Blood Transfusion
|
January 1, 1987
Long-term results of two Swiss AML studies
C Sauter, P Alberto, W Berchtold, et al.
Journal of the Endocrine Society
|
December 22, 2017
Temperature as a Circadian Marker in Older Human Subjects: Relationship to Metabolic Syndrome and Diabetes
Brianna D Harfmann, Elizabeth A Schroder, Jonathan H England, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2015
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
A S Coates, E P Winer, A Goldhirsch, et al.
British Journal of Cancer
|
November 1, 1996
Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy. Swiss Group for Clinical Cancer Research (SAKK)
J Bernhard, C Hürny, M Bacchi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 1, 1993
The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG)
C Hürny, J Bernhard, M Bacchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study Group
C Hürny, J Bernhard, A Coates, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group
C Hürny, J Bernhard, R D Gelber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1995
Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK)
R A Joss, M Bacchi, C Hürny, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1986
Swiss adjuvant trial (OSAKO 06/74) with chlorambucil, methotrexate, and 5-fluorouracil plus BCG in node-negative breast cancer patients: nine-year results
H J Senn, W F Jungi, R Amgwerd, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1995
Interferon-alpha for induction and maintenance in multiple myeloma: results of two multicenter randomized trials and summary of other studies
H Ludwig, A M Cohen, A Polliack, et al.
Page
of 20